Company plans to expand its executive, business development, science, sales, and marketing teams
PRINCETON, NJ – Mar. 17, 2015 – Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that as a result of its rapid growth, the company is moving its corporate headquarters to a larger location in Princeton, NJ.
“Demand for our biosimulation solutions is increasing because it is now recognized by biopharmaceutical companies and regulatory agencies around the world as an integral part of the drug development process. Biosimulation can help to determine the appropriate dose for a drug entering clinical trials, identify possible drug-drug interactions, recommend the pediatric dose for a drug when there is only adult data available, and in some cases remove the need for conducting an additional clinical trial. As the leading company in biosimulation, we are actively advancing this area of science to help bring new, safer therapies to patients,” said Certara’s Chief Executive Officer Edmundo Muniz, M.D., Ph.D.
“In addition, as the call for greater transparency in clinical studies grows louder, and new regulations are introduced, biopharmaceutical companies are experiencing an increasing need for our Clinical Redaction Management Service, which removes private patient and company details from clinical trial information before it is published,” Dr. Muniz added.
Certara’s executive team will move into its new headquarters right away, where there is ample space for growth. In addition to increasing its executive team, Certara also plans to expand its business development, science, sales, and marketing presence in Princeton. It may also add new members to its medical regulatory writing and consultancy teams.
This new location also includes a world-class education center in which Certara can conduct scientific and product training. Educating the life science industry on biosimulation, regulatory strategy, and clinical trial data transparency and disclosure issues are core elements of the company’s mission.
Certara’s new headquarters is located at 100 Overlook Center, Suite 101, Princeton, NJ 08540.
Certara is the global biosimulation technology-enabled drug development and drug safety consulting company. Its customers include hundreds of biopharmaceutical companies around the globe, together with several regulatory agencies. Certara’s solutions, which span the discovery, preclinical and clinical stages of drug development, enable data-driven decisions, leading to more precisely designed trials with a reduced risk of failure and improved subject safety. For more information, visit http://www.certara.com.
Ellen Leinfuss, 609-216-9586
Chief Marketing Officer
Lisa Osborne, 206-992-5245
Rana Healthcare Solutions